Sjöholm A G, Sturfelt G
Acta Pathol Microbiol Immunol Scand C. 1984 Oct;92(5):265-9. doi: 10.1111/j.1699-0463.1984.tb00086.x.
A cleavage product of C2, C2a was demonstrated by crossed immunoelectrophoresis in serum and EDTA plasma from patients with active systemic lupus erythematosus (SLE), patients in the early phase of acute poststreptococcal glomerulonephritis (AGN), and from two males with congenital deficiency of C1(-) inactivator, one of whom had symptoms of hereditary angioedema. C2a was not found in normal serum and plasma. C2 was more stable in plasma than in serum with regard to the effects of storage in room temperature and of repeated freezing and thawing. C2a concentrations were higher in serum than in plasma samples from SLE and AGN patients. Expressed in per cent of the total C2 protein, C2a was inversely correlated (r = -0.91) with the C2 hemolytic activity in the samples, which explains discrepancies between the results of immunochemical and functional assays, when used to measure C2 concentrations in disease.
通过交叉免疫电泳在活动期系统性红斑狼疮(SLE)患者、急性链球菌感染后肾小球肾炎(AGN)早期患者以及两名先天性C1(-)灭活剂缺乏的男性(其中一人有遗传性血管性水肿症状)的血清和乙二胺四乙酸(EDTA)血浆中证实了补体C2的裂解产物C2a。在正常血清和血浆中未发现C2a。就室温储存以及反复冻融的影响而言,C2在血浆中比在血清中更稳定。SLE和AGN患者的血清中C2a浓度高于血浆样本。以总C2蛋白的百分比表示,C2a与样本中的C2溶血活性呈负相关(r = -0.91),这解释了在疾病中用于测量C2浓度时免疫化学和功能测定结果之间的差异。